Related Experiment Video
Updated: Jul 6, 2026
09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
Mammographic density--a risk factor for breast cancer
1Department of Gynaecology and Obstetrics, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic. tfait@seznam.cz
Prague Medical Report
|April 11, 2008
Summary
Mammographic density is a breast cancer risk factor, but temporary increases from hormone therapy do not pose the same risk. Density changes from hormone use resolve after treatment cessation.
Area of Science:
- Radiology and Oncology
- Women's Health
Background:
- Mammographic density is a significant risk factor for breast cancer.
- Increased mammographic density can lead to inaccurate mammogram results (false negatives/positives).
Purpose of the Study:
- To differentiate mammographic density changes due to hormone replacement therapy (HRT) from inherent risk factors.
- To clarify the implications of HRT-induced density changes on breast cancer risk and screening.
Main Methods:
- Review of literature on mammographic density and hormone replacement therapy.
- Analysis of the transient nature of density changes during and after HRT.
Main Results:
- Mammographic density increases during HRT are distinct from the density associated with elevated breast cancer risk.
- These HRT-related density changes are reversible, typically receding within 14 days of treatment withdrawal.
- High mammographic density does not contraindicate HRT but may influence treatment choice.
Conclusions:
- Temporary increases in mammographic density during HRT should not be equated with the density that signifies increased breast cancer risk.
- The reversibility of HRT-induced density changes is a key distinction.
- Treatment selection for HRT may consider tibolone and estrogen replacement therapy over estrogen-gestagen options in cases of high mammographic density.
